EcoDrugPlus

Adenosine Receptor A1-Like

Ensembl ID : ENSOMEG00000020524
Gene Symbol: LOC112159329
3 Cross references
173 Possible Orthologues:

Adenosine Receptor A2a-Like

Ensembl ID : ENSOMEG00000021428
Gene Symbol: LOC112147988
3 Cross references
189 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSOMEG00000016769
Gene Symbol: ADRA1B
3 Cross references
193 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSOMEG00000008810
Gene Symbol: ADRA1D
3 Cross references
194 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSOMEG00000007601
Gene Symbol: ADRA2A
3 Cross references
159 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSOMEG00000017256
Gene Symbol: ADRA2C
1 Cross references
160 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSOMEG00000010039
Gene Symbol: ADRA2C
2 Cross references
157 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSOMEG00000003986
Gene Symbol: ADRB1
1 Cross references
161 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSOMEG00000007249
Gene Symbol: ADRB2
3 Cross references
192 Possible Orthologues:

Adrenoceptor Beta 3a

Ensembl ID : ENSOMEG00000009721
Gene Symbol: ADRB3A
1 Cross references
196 Possible Orthologues:

Aldo-Keto Reductase Family 1 Member B

Ensembl ID : ENSOMEG00000012739
Gene Symbol: AKR1B1
3 Cross references
336 Possible Orthologues:

Aldo-Keto Reductase Family 1 Member B10-Like

Ensembl ID : ENSOMEG00000012798
Gene Symbol: LOC112153991
3 Cross references
343 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).